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Osteoarthritis (OA) is the most prevalent type of arthritis that is caused by the
breakdown and eventual loss of the cartilage of one or more joints. However, OA
develops most frequently in the absence of a known cause. Mechanical, bioche-
mical, and genetic factors are involved in the etiology of OA. In recent years,
apoptotic death of articular chondrocytes has been implicated in the pathogenesis
of human and animal OA. There are numerous mediators that may induce
apoptosis in chondrocytes in vitro, but it is likely that far fewer will function in
vivo. Among these, the key players are the free radical nitric oxide (NO),
1 Fas and
its ligand FasL,
2,3 and pro-inflammatory cytokines such as tumor necrosis factor
(TNF)-α.
4 It is becoming more and more evident that chondrocyte apoptosis plays
an important role in cartilage destruction. Recent studies suggest that peroxisome
proliferator-activated receptor gamma (PPAR-γ) may be associated with the
apoptosis of chondrocyte.
5
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Purpose: The purpose of this study was to study the protective effect and influence of sodium hyaluronate (Na-
HA) on mRNA expression of peroxisome proliferators-activated receptor gamma (PPAR-γ) in cartilage of rabbit
osteoarthritis (OA) model. Materials and Methods: Forty eight white rabbits were randomly divided into A, B,
and C groups. Group A was normal control group, B and C groups underwent unilateral anterior cruciate ligament
transection (ACLT). The rabbits in group B were injected normal saline after ACLT; and Group C received intra-
articular1% sodium hyaluronate (HA) injection 5 weeks after surgery, 0.3 mL once a week. At 11th week after
surgery, all the rabbits were sacrificed. The cartilage changes on the medial femoral condyles were graded
separately. Cartilage sections were stained with safranin-O and HE, and messenger RNA (mRNA) expression of
PPAR-γ was detected by using real time polymerase chain reaction (Real Time-PCR). Results: Cartilage
degeneration in group B was significantly more severe than in A and C injection group. The grey value of Safranin-
O of B group was higher than A and C groups. Expression of PPAR-γ mRNA in group B was higher than group A
and C. Conclusion: This study shows that Na-HA has a protective effect on articular cartilage degeneration, and
the inhibitory effect on the PPAR-γ mRNA expression may be one of therapeutic mechanism of Na-HA. 
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INTRODUCTIONHowever, there are only a few reports about the effect of
HA on the messenger RNA (mRNA) expression of PPAR-
γ, and the mechanisms of therapeutic effect of hyaluronate
(HA) on OA remain to be elucidated. In this study, we
determined the protective effect of HA on articular cartilage
and the expression of PPAR-γ mRNA in experimentally
induced OA rabbits.
Experimental groups
Forty eight mature New Zealand white rabbits, weighing
2.2-2.8 kg, were used, and randomly divided into three
groups. Group A was normal control, and animals in group B
and C were anesthetized intravenously with ketamine hyd-
rochloride (1.0 mg/kg), and received unilateral anterior
cruciate ligament transection (ACLT). A medial parapa-
tellar incision was made on the skin, and a medial arthro-
tomy was performed. The patella was dislocated, and the
knee was placed in full flexion. The ACL was visualized and
transected without destroying the articular cartilage. The knee
was irrigated with physiological saline. Then, the capsule
and skin were closed, and  the animal was individually
kept in a cage (60 cm×60 cm×40 cm) without any immo-
bilization and maintained under the same environmental
condition.
6 On the 5th week after surgery, group B animals
were injected with 0.3 mL normal sodium (NS) after
ACLT, and animals in group C received 0.3 mL of intra-
articular1% sodium HA injection, once a week for 5 weeks.
All animals were killed at 11 weeks following surgery. 
Gross macroscopy
Evaluation of the cartilage damages was performed by two
observers. Qualitative macroscopic evaluation of cartilage
injuries was performed by one investigator. Cartilage
damages were reported in a semi-quantitative grading table
modified from the human literature with a five-grade scale
(0 = normal; 1 = surface striations or tears; 2 = bucket handle
or transverse tears; 3 = fibrillation of the entire cartilage,
protrusion; 4 = loss of cartilage, or ulcer).
Microscopy
Tissues from 8 rabbits of each group were dissected, fixed
48 h in neutral buffered 4% formaldehyde in 0.1 M sodium
phosphate buffer (PBS), pH = 7.4, decalcified 3-4 weeks in
10% ethylenediaminetetraacetic acid (EDTA), dehydrated
in graded alcohols, and embedded in paraffin. Sections, 5
µm thick, were stained with both hematoxylin and eosin
for general morphology, or with 0.1% safranin-O and fast
green to demonstrate sulfated proteoglycans (PGs). The
area of positively stained safranin-O metachromasia, indi-
cative of PGs, and the total area of the joint cartilage in
frontal sections were measured. Each data point represents
results obtained from measurements of two sections from
each of three individual animals belonging to the same
group. 
Real-time quantitative polymerase chain reaction
Cartilage tissue from the medial femoral condyle was
harvested from the operated knee, and was frozen in liquid
nitrogen. The samples were powdered in liquid nitrogen by
hand milling. The total RNA was extracted by using the
Trizol reagent (Invitrogen Technologies, Carlsbad, CA,
USA) according to the manufacturer’s protocol. The RNA
samples were spectrophotometrically quantified at A260.
Then, RNA was reverse-transcribed to cDNA using RT-
PCR kit (TaKaRa, Dalian, China) according to protocol.
The cDNA was analyzed immediately or stored at -20˚C.
Quantitative-polymerase chain reaction (PCR) amplifica-
tion was performed by ABI 7900HT Fast Real-Time PCR
System (ABI Company, Forst City, CA, USA) and the
SYBR Green I fluorescent dye method was used to quan-
tify cDNA. The sequences of the primers used are shown
in Table 1.
The final volume of the RT-PCR reaction was 10 µL
and included SYBR Premix Ex Taq 5 µL, primer (10
µmol/L) 0.2 µL each, 50× ROX Reference Dye 0.2 µL,
template 1 µL, adjusted to 10 µL with distilled water. PCR
cycling conditions consisted of an initial denaturing step
for 10 seconds at 95˚C, and then 40 cycles of 5 seconds at
95˚C, and 30 seconds at 60˚C. A stable and reliable standard
curve was established using synthesized oligonucleotides
resembling complementary DNA (cDNA) fragments in 5-
fold decrements as template. The glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) from the same sample
was used as internal control, and the relative contents of
copy numbers of the target gene’s mRNA were calculated,
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MATERIALS AND METHODS
Table 1.Details of the Primers Used in This Study 
Gene Primer sequence (5’- 3’) Product size Reference          
PPAR-γ GTCGCCATCCGCATCT 758bp AF013266 
CATGGACGCCGTACTTGA 
GAPDH CCACCTTGTGAAGCTCATTTCCT 1282bp NM001082253
TCGTCCTCCTCTGGTGCTCT
PPAR-γ, peroxisome proliferator-activated receptor gamma; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.through which we could determine the gene expression
level and its trend of change. Specificity of each reaction
was controlled by melting curve analysis. A negative PCR
control containing water instead of cDNA was performed.
Real-time PCR was conducted in triplicate in three inde-
pendent experiments.
Statistical analysis
All values were expressed as mean ± SE. Statistical analysis
was performed using SPSS 12.0 (SPSS Inc., Chicago, IL,
USA) software package. Results were evaluated by ANOVA.
p< 0.05 was accepted as significance level.
Macroscopic findings
The cartilage on condyles of normal rabbits was macrosco-
pically normal. In NS-treated OA rabbits, cartilage lesions
of moderate grade and size were present on condyles,
Rabbits treated with HA presented a marked reduction in
the severity of lesions on the condyles (Table 2).
Microscopic findings
Cartilage from normal rabbits had a normal histologic
appearance, specimens from NS-treated OA rabbits had
morphologic changes, including cartilage fibrillation and
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RESULTS
Fig. 1. Representative sections of cartilage from the femoral condyles (HE staning). (A) Cartilage of normal showing no evident changes. (B) NS
group showing loss of height of articular cartilage, increased flaking of cartilage, clefts deep to the radial zone, loss of coumnization of cellular
distribution, and increased areas of hypocellularity. (C) HA could protect articular cartilage from loss of height, and decrease the flaking of cartilage.
NS, normal sodium treated group; HA, sodium hyaluronate treated group.
ABC
Fig. 2. Representative sections of cartilage from the femoral condyles (Safranin-O staining). (A) Cartilage of normal showing an intact profile, and
there is no evident loss of proteoglycan (PGs). (B) NS group showing severe loss of PGs, and clefts deep to the radial zone. (C) HA could inhitit the
loss of PGs in cartilage matrix.
ABC
Table 2.Macroscopic Grading of Cartilage  
Groups 0 1 2 3 4 
NOR 6 2 0 0 0
NS 0 1 1 3 3
HA 0 5 2 1 0
NOR, normal control group; NS, normal sodium treated group; HA, sodium 
hyaluronate treated group.
There is no difference between NOR and HA group (p> 0.05), and significant
difference between NS and NOR, HA group (p< 0.05).
Table 3.Grey value of Safranin-O of Cartilage Section 
Groups Grey value (x ± s)
NOR 146.9 ± 7.3
NS 174.1 ± 10.8
HA 158.2 ± 11.3
NOR, normal control group; NS, normal sodium treated group; HA, sodium 
hyaluronate treated group.
There are significant difference between NS and NOR, HA groups (p< 0.05).fissures, and a loss of Safranin 0 staining (Figs. 1 and 2). In
the HA-treated OA rabbits, the lesions on the condyles
were significantly less severe (p < 0.05) compared with the
NS-treated OA rabbits. This difference was largely due to a
decrease in severity of structural changes and loss of
Safranin 0 staining (Fig. 2). 
Level of PPAR-γ γmRNA 
Standard curve
Based on the relationship between the concentration of
GAPDH and Ct value, a standard curve with high relativity
(r = 0.9949) was obtained (Fig. 3). 
Expression level of PPAR-γmRNA in cartilage
Fig. 4 and 5 show the amplification plot and dissociation
curve of PPAR-γ and GAPDH, respectively. The results of
PPAR-γ mRNA expression were rectified by the control
gene (GAPDH mRNA). Shown in Fig. 6 are the values
that represent steady-state levels of PPAR-γ mRNA relative
to GAPDH mRNA. PPAR-γ mRNA levels determined by
quantitative RT-PCR indicated an approximate increase
(1.5-fold) in the cartilage of NS-treated group compared
with the normal group (p < 0.05). There was no significant
different in the PPAR-γ mRNA expression between HA-
treated group and normal group (p> 0.05).
An imbalance between synthetic and catabolic processes
affecting components of the extracellular matrix can result
in destruction of articular cartilage. Because articular
chondrocytes are the only cells residing in cartilage tissue,
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DISCUSSION
Fig. 3. Stand curve of GAPDH in fluorescent quantitative PCR. PCR, polymerase
chain reaction; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
Fig. 5. Dissociation curve of PPAR-γ and GAPDH. PPAR-γ , peroxisome
proliferators-activated receptor gamma; GAPDH, glyceraldehyde 3-phosphate
dehydrogenase.
Fig. 6. Real Time PCR for the relative expression of PPAR-γ mRNA in cartilage.
There was significant difference between NS and NOR, HA cartilage (p< 0.05),
and no difference between NOR and HA cartilage (p > 0.05). PCR, polymerase
chain reaction; PPAR-γ , peroxisome proliferators-activated receptor gamma;
mRNA, messenger RNA; NS, normal sodium treated group; NOR, normal control
group;  HA, sodium hyaluronate treated group.
Fig. 4. Amplification plot of PPAR-γ and GAPDH. PPAR-γ , peroxisome
proliferators-activated receptor gamma; GAPDH, glyceraldehyde 3-phosphate
dehydrogenase.these resident cells are highly specialized and solely
responsible for the maintenance and turnover of extra-
cellular matrix macromolecules including type II collagen,
aggregating proteoglycans and noncollagenous proteins.
7
Therefore, so their survival is essential for maintaining
proper architecture of the articular cartilage. In OA cartilage,
hypocellularity and matrix degeneration are believed to
contribute to joint degradation.
8,9 Numerous studies have
demonstrated significant involvement of apoptosis of
chondrocyte in the pathologic degradation of the cartilage
matrix. It is becoming more and more evident that apoptosis
of chondrocytes plays an important role in cartilage dest-
ruction. However, in cartilage, there are no macrophages.
In those conditions, secondary necrosis would inevitably
result in uncontrolled release of lysosomal enzymes from
apoptotic bodies causing serious damages to the extracel-
lular matrix.
10 There are numerous mediators that potently
induce apoptosis in chondrocyte cultures, although the
mechanisms involved are not yet fully elucidated. These
mediators include nitric oxide,
1 Fas and its ligand FasL,
2,3
and Bcl-2/Bax family members.
11 One member of the
prostaglandins (PGs) family, PG E2, has been reported to
induce bovine chondrocyte apoptosis.
12
However, the chondrocyte apoptosis of OA could not
entirely be attributed to these mediators. Nevertheless,
many recent investigations have been focused on the
possible role of PPAR-γwhich is a transcriptional factor that
belongs to the nuclear receptor superfamily.
13,14 PPAR-γ
mRNA expression level in chondrocytes was up-regulated
by the proinflammatory cytokines IL-1β and TNF-1α.
Specifically, the two synthetic PPAR-γ agonists, ciglita-
zone and pioglitazone, induced chondrocyte apoptosis.
5
Therefore, PPAR-γ could be a potential target to modulate
the effects of cytokines on cartilage.
15 Furthermore, activa-
tion of PPAR-γ by ciglitazone in growth plate chon-
drocytes inhibits T3-induced terminal differentiation and
promotes apoptosis through increased levels of caspase 3/7
activity and decreased expression of the anti-apoptotic
protein Bcl-2,
16 and Yoon, et al.
17 reported that the PPAR-γ
agonist, 15-deoxy-∆12,14-prostaglandinJ2 (15d-PGJ2),
causes articular chondrocytes dedifferentiation and induces
COX-2 expression and PGE2 production of chondrocytes.  
In the present studies, we demonstrated that PPAR-γ is
synthesized by chondrocytes of both NOR and OA articular
cartilage in rabbit. Real Time PCR analyze showed that
NOR and OA cartilage express the PPAR-γ mRNA, and
that there is a significant increase in cartilage sample of
OA. And activation of PPAR-γ in these cells may result in
activation of a pathological form of apoptosis.
16 Intra-arti-
cular injection of hyaluronan (Na-HA) has widely been
used in the treatment of OA. Na-HA is one of the important
components of cartilage matrix, and has a protective effect
on the progression of OA. Injection of exogenous HA can
inhibit prostaglandin E2 (PGE2) synthesis, induced by
interleukin-1 (IL-1),
18,19 and protect against proteoglycan
depletion and cytotoxicity induced by oxygen-derived free
radicals, IL-1, and mononuclear cell-conditioned medium,
as well as other alterations.
20-22 Na-HA is also reported to
inhibit the expression of matrix metalloproteinase (MMP-
1) and MMP-3 induced by interleukin-1β.
23 In our study,
the lesions on the condyles in HA treated group were
significantly less severe compared with the NS-treated OA
rabbits, and the severity of structural changes and loss of
Safranin 0 staining were decreased.
In conclusion, our present studies demonstrated that
PPAR-γ is involved in the progression of OA, and that the
activation of PPAR-γ in chondrocytes may result in activa-
tion of a pathological form of apoptosis. Exogenous Na-
HA could protect cartilage degeneration, at last partly,
through inhibition of PPAR-γ mRNA synthesized by
chondrocytes of OA articular cartilage in rabbit. However,
we could not detect the isoforms of PPAR-γ, and also did
not determine the influence of Na-HA on them. The
mechanism needs to be further investigated, and PPAR-γ,
may be the novel therapeutic target in OA. 
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